Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid dose comparison on coronary perfusion during CABG
IRCT20180724040575N3Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tranexamic acid in coronary arteriosclerosis (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Creatine kinase-MB change and Troponin change. Started Aug 2018; status: completed.
02
Drugs
tranexamic acid
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20180724040575N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180724040575N3.